Page last updated: 2024-12-08

phosphorodithioic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dithiophosphoric acid : A phosphorothioic acid that is the phosphoric acid having two of its oxygen atoms replaced by sulfur atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID152119
CHEMBL ID4210072
CHEBI ID74944
MeSH IDM0221257

Synonyms (17)

Synonym
dithiophosphoric acid
15834-33-0
phosphorodithioic acid
unii-8056rr93hu
8056rr93hu ,
phosphorodithioic o,o,s-acid
dithioorthophosphoric acid
CHEBI:74944
hsp(s)(oh)2
thiolothionophosphoric acid
NAGJZTKCGNOGPW-UHFFFAOYSA-N
dithiophosphorsaure
DTXSID0075312
Q27145029
dioxido-sulfanylidene-sulfido-lambda5-phosphane;hydron
dihydroxy-sulfanyl-sulfanylidene-lambda5-phosphane
CHEMBL4210072

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"To investigate the toxic effects of high-dose Bcl-2 antisense phosphorothioate oligodeoxynucleotides (AS-PS-ODN, ASPO) incubation on HL60 cells and to understand the relationship between the dose of ASPO and the toxicity."( [The toxic effects of high-dose Bcl-2 antisense phosphorothioate oligodeoxynucleotides incubation on cell line].
Chen, Z; Lin, Y; Lü, L, 2000
)
0.31
" The sense (PS-ODN, SPO) was chosen for the toxic control of independent sequence."( [The toxic effects of high-dose Bcl-2 antisense phosphorothioate oligodeoxynucleotides incubation on cell line].
Chen, Z; Lin, Y; Lü, L, 2000
)
0.31
" When the dose of PS-ODN reached 262 micromol/L, the toxic effect had no significant differences between Bcl-2 ASPO and Bcl-2 SPO."( [The toxic effects of high-dose Bcl-2 antisense phosphorothioate oligodeoxynucleotides incubation on cell line].
Chen, Z; Lin, Y; Lü, L, 2000
)
0.31
"Although ASPO is a kind of low-toxic drug, the toxic effects of Bcl-2 ASPO seem to be dependent on the dose increasing to a certain extent."( [The toxic effects of high-dose Bcl-2 antisense phosphorothioate oligodeoxynucleotides incubation on cell line].
Chen, Z; Lin, Y; Lü, L, 2000
)
0.31
" AS-HIF treatment did not affect viability of primary astrocytes and was selectively more toxic to U-87 glioma cells than normal human fibroblasts."( Inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells.
Chao, KS; Dai, S; Hsu, CY; Huang, ML, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phosphorothioic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1370007Drug level treated with UTP 5'-O-Palpha,alpha-dithiophosphate at 2 mM at pH 11.7 at room temperature after 25 days by 31P NMR method2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
AID1370016Drug level treated with UTP 5'-O-Palpha,alpha-dithiophosphate-beta,gamma-methylene at 2 mM at pH 11.7 at room temperature after 25 days by 31P NMR method2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
AID1370012Drug level treated with diuridine 5'-O-Palpha,alpha,5''-O-Palpha,alpha-tetrathiotetraphosphate at 2 mM at pD 12.6 at room temperature after 16 days by 31P NMR method2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (118)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (4.24)18.7374
1990's3 (2.54)18.2507
2000's55 (46.61)29.6817
2010's45 (38.14)24.3611
2020's10 (8.47)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.16 (24.57)
Research Supply Index4.87 (2.92)
Research Growth Index5.24 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (5.43%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other122 (94.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]